At what PSA level would you consider restaging a patient who was treated with ADT and radiation and had undetectable PSA?  

At what PSA would you become suspicious for biochemical recurrence and pursue restaging? Is there a threshold value?

What imaging modality would you use for restaging - PSMA PET or Axumin PET or CT and bone scan?

Answer from: Medical Oncologist at Academic Institution
Radiation Oncologist at National Cancer Institute
Why is 2.1 actionable but 1.9 is not? In other wor...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice